Publication | Closed Access

Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

InflammationArpe-19 CellsMedicineImmunologyCell DeathToxicologyPharmacotherapyOxidative Stress ConditionsRepeated-dose Toxicity StudyReactive Oxygen SpecieExperimental ToxicologyPharmacologyToxicological MechanismOxidative Stress